|
Please note, this site is intended for non-US audiences only.

|
TMC 114
|


|
TRIAL
|
PHASE
|
STATUS
|
PATIENT PROFILE
|
COUNTRIES
|
PUBLICATIONS
|

|

|

|

|

|

|
| TMC114-C207 |
lla |
Completed |
Multiple PI- experienced HIV-1 infected subjects failing ART* |
Austria, Belgium, Germany, Italy, Poland, Switzerland, UK |
In press Poster at IHDRW
|

|

|

|

|

|

|
| TMC114-C213 |
llb |
Ongoing |
3-class experienced HIV-1 infected subjectswith at least 1 primary PI mutation |
Australia, Austria, Belgium, Brazil, Canada, France, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland, UK |
 |
|
TMC114-C202
|
llb |
Ongoing |
3-class experienced HIV-1 infected subjectswith at least 1 primary PI mutation |
Argentina, USA |
 |

|

|

|

|

|

|
|
TMC114-C214
|
III |
Ongoing |
ARV treatment-experienced HIV-1 infected subjects |
Australia, Argentina, Austria, Bahamas, Belgium, Brazil, Canada, Costa Rica, Chile, Denmark, France, Germany, Greece, Guatemala, Hungary, Malasia, Mexico, Panama, Portugal, Russia, South Africa, Spain, Switzerland, Thailand, The Netherlands, UK, US, Venezuela |
 |
|
ART* = antiretroviral therapy


|
|
|
|
|
|
|